At UHN, we strive to deliver Compassionate Care & Caring. Learn more about the services and supports that are available to you throughout your journey.
Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
At the heart of everything we do at UHN are our Healthcare Professionals. Refer a patient to one of our 12 medical programs. Learn more about the resources and opportunities available for professional growth.
University Health Network has grown to be one of the largest research and teaching hospital networks in Canada - pioneers in improving the lives of patients. Our long history of health professions education at Toronto General, Toronto Western, Princess Margaret and Toronto Rehab hospitals has consistently advanced the science of education.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It's also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
The McEwen Stem Cell Institute brings scientists, clinicians, investors and philanthropists together to work as a team to advance translation of stem cell research to therapy.
Gordon M. Keller, PhD
Michael Laflamme, MD, PhD
Maria Cristina Nostro, PhD
Shinichiro Ogawa, MD, PhD
Stephanie Protze, PhD
We are laser focused on four branches of discovery that hold the greatest promise to translate from theory to therapy.
Regeneration of the blood system through the transplantation of blood-forming stem cells (commonly referred to as a bone marrow transplantation) is an effective treatment for a range of blood cell diseases, including leukemia.
Beta cells produced from human pluripotent stem cells (hPSCs) represent a new and potentially unlimited source of these cells for transplantation for the treatment of type 1 diabetes.
Transplantation of cardiomyocytes (heart muscle cells) produced from human pluripotent stem cells (hPSCs) offers a potential new therapy that could, for the first time, remuscularize and repair the heart.
It is estimated that more than three million Canadians have chronic liver disease and the incidence of some forms is increasing dramatically. Progression to liver failure requires transplantation of a new organ.
Our Accelerated Discoveries program puts scientists, investors and philanthropists together to help us move from theory to therapy with astonishing speed. Learn more about our partners.
